[Study on "cui xing an" in lowering intraocular pressure and miosis. Part II. Preliminary observation on its therapeutic effect on primary open-angle glaucoma].
D000293:Adolescent; D000328:Adult; D000470:Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D008916:Miotics / Q000627:therapeutic use*; D014785:Vision, Ocular / Q000187:drug effects
D000470:Alkaloids; D002800:Cholinesterase Inhibitors; D008916:Miotics; C034764:cui xing an